Case type IVF & Fertility Treatment Injuries
PGT-SR Testing Errors

You or your partner carries a translocation or other chromosome rearrangement, you used PGT-SR to choose an embryo, and a later result does not match the report. Tell us your story.
CBW Law reviews possible PGT-SR testing errors for families nationwide. We look at whether the testing method fit the rearrangement, how samples were tracked and what the report and counseling told you. Some results reflect real limits of the test, and we will be clear about that. Tell Us Your Story. Contacting us does not create an attorney-client relationship.
PGT-SR helps parents who carry a chromosome rearrangement find embryos without a harmful imbalance. What it can show depends heavily on the lab's method, and some methods cannot tell a balanced carrier embryo from one with the usual arrangement. A result can be wrong because of a known limit of the test, or because of a mislabeled sample, a poor choice of method or a report that overstated what the test could see. A PGT-SR lawyer can help you understand which happened.
What PGT-SR testing is and why it may be offered
PGT-SR stands for preimplantation genetic testing for structural rearrangements. It is used when a parent carries a chromosome change in which pieces of chromosomes have broken and rejoined in a new arrangement. Embryos from that parent are at risk of gaining or losing chromosome material, and PGT-SR looks for those imbalances before transfer1.
Rearrangements include reciprocal and Robertsonian translocations, insertions, deletions, duplications and inversions. They can be inherited or new. Inherited reciprocal and Robertsonian translocations are the most common reasons for PGT-SR2. Before testing, the lab works from the carrier parent's karyotype, a detailed picture of that person's chromosomes2.
The goal is to find unbalanced embryos at the earliest stage2. When the test can detect all the unbalanced forms, it may lower the risk of miscarriage, stillbirth or a baby with an unbalanced rearrangement2. ESHRE warns that a test unable to detect every segment may be less effective at lowering those risks2. ACOG describes the clinical usefulness of PGT-SR as firmly established1.
Balanced and unbalanced rearrangements, in plain terms
Think of chromosomes as a set of instruction books. In a rearrangement, pages have been moved from one book to another or put in backward. What matters most is whether any pages are missing or extra3:
- Balanced: no genetic material is gained or lost, just arranged differently3. A balanced change may have no effect on the carrier's health3.
- Unbalanced: some genetic material is missing or extra3. This can lead to miscarriage, stillbirth or problems with growth and development23.
- Translocation: a piece of one chromosome breaks off and attaches to another3.
- Inversion: a chromosome breaks in two places and the piece is turned around and put back3.
A balanced carrier can make eggs or sperm that lead to unbalanced embryos, as well as embryos that carry the balanced form or the usual arrangement24. The effects of an unbalanced change depend on its size and location3.
How PGT-SR compares with PGT-A and PGT-M
- PGT-SR looks for gains or losses tied to a known parental rearrangement1.
- PGT-A screens all chromosomes for extra or missing copies, usually for patients without a known rearrangement21.
- PGT-M tests for one gene variant that runs in a family1.
Some methods check the other chromosomes too. Array-based PGT-SR can assess chromosomes not involved in the rearrangement in the same test2. A single report may therefore answer more than one question, and it should say which ones.
Why the testing method matters
Not all PGT-SR tests give the same information. The method decides how small a change the lab can see and whether it can tell a balanced carrier embryo from one with the usual arrangement.
What different PGT-SR methods can and cannot show
- FISH
- Uses colored probes for chosen chromosome regions. It sees only the regions the probes target and cannot tell normal from balanced embryos2.
- Array CGH
- Reads copy number across the genome, with a resolution of about 5 to 10 million base pairs. It cannot tell normal from balanced embryos, and segments below its resolution may be missed2.
- Standard NGS
- Counts DNA reads by chromosome. Without added genotyping it cannot tell balanced from normal results, detect whole ploidy changes, or catch low-level mosaicism or changes below its resolution2.
- SNP array and haplotyping
- Can tell balanced carrier embryos from non-carrier embryos using haplotypes. The lab first needs DNA from the couple and a reference, ideally a relative who carries the balanced form; without one, it may rely on an unbalanced embryo from the cycle2. A 2022 study reported that a low-coverage sequencing method with haplotype analysis matched amniocentesis results in all 15 ongoing pregnancies it followed4.
ESHRE says a clinical PGT-SR test should not be done if the rearranged segments are smaller than the platform can detect, and that the work-up report should say when some unbalanced forms cannot be detected2. Counseling should also explain whether the chosen method can separate normal from balanced results5.
If you are unsure what your test could see, ask the clinic or lab which platform was used, its resolution and whether it reported carrier status. Those details often sit in the work-up report rather than on the page listing embryo results.
Sample, analysis and reporting errors in PGT-SR
Some failures come from the test's limits. Others come from avoidable mistakes. Examples of preventable problems include:
- Sample errors: tubes mislabeled, swapped or contaminated during biopsy or shipping (see genetic testing sample mix-ups)
- Analytical errors: a method chosen that cannot detect the parent's rearranged segments
- Work-up errors: a test planned from a parental karyotype that was wrong or not detailed enough (ESHRE calls for a high-resolution karyotype in the file)2
- Interpretation errors: a mosaic or partial result read as clearly balanced or unbalanced
- Reporting errors: results attached to the wrong embryo, or carrier status reported when the method could not show it
- Communication errors: limits, undetectable forms or residual risk never explained
Good-practice guidance calls for labeling each sample with two unique patient identifiers plus the embryo number, with an independent check at high-risk steps. After a misdiagnosis, the center should investigate and change its protocols5.
Residual risk, genetic counseling and confirmatory testing
No PGT-SR result removes all risk. ESHRE says counseling should include the chance of a viable unbalanced pregnancy if the test misses an unbalanced form, and the patient's file should hold a high-resolution parental karyotype, a counseling report on the method's benefits and limits, and informed consent with a risk assessment2.
ACOG says a normal or negative result does not ensure a newborn without genetic abnormalities. It adds that diagnostic testing or screening is especially important after PGT-SR when PGT-A was not also performed1. ESHRE guidance also says patients should be told about prenatal diagnosis to confirm a PGT result5. For rearrangements involving certain chromosomes, ESHRE notes an increased risk of uniparental disomy and says prenatal testing for it should be assessed case by case2.
Whether to have prenatal testing is your decision, made with your care team. Choosing not to have it does not cause or excuse a testing error. For a broader comparison of what each type of embryo test can miss, see PGT results and testing limitations.
When a test cannot tell you something, you deserve to hear that before you decide which embryo to transfer.
Possible consequences of a PGT-SR error
A wrong or poorly explained PGT-SR result can affect a pregnancy, a child and a family's future plans:
- Transfer of an embryo with an unbalanced rearrangement, leading to miscarriage or stillbirth
- A child born with a chromosome imbalance the testing was meant to detect
- Balanced or normal embryos discarded because of a wrong report
- A child who carries the balanced form, when the family was told the method could rule it out
- More IVF cycles, more cost and more time
- Grief, worry about future pregnancies and strain on the family
Where the law stands on PGT-SR claims
Claims involving PGT-SR are decided case by case under state law. Some states limit claims tied to the birth of a child, as our PGT-M page explains with an Arizona example. Proposed class actions over PGT-A marketing have also reached federal courts, as discussed on our PGT-A page. Each of these is a different kind of case, and an individual PGT-SR error depends on its own records.
When a PGT-SR lawyer may help
Consider talking to a lawyer about a possible PGT-SR testing error if:
- Prenatal or newborn testing found an imbalance involving the parent's rearrangement
- Your report described carrier status, but the lab's method could not show it
- Your file does not name the method used or its limits
- Embryo numbers, names or dates in the report do not match clinic records
- Embryos were discarded based on a result later shown to be wrong
A claim review compares the parental karyotype with the method chosen, follows each sample from biopsy to report and checks what you were told before you consented and before transfer.
Who may be responsible for a PGT-SR error
- The PGT lab that chose the method, analyzed the samples and wrote the report
- The fertility clinic and physician who ordered testing and chose embryos
- The embryology lab that performed the biopsy and labeled samples
- The cytogenetics lab that reported the parent's karyotype
- A genetic counselor who explained, or did not explain, the test's limits
Responsibility is never assumed. A PGT-SR attorney looks at each party's role in the records.
Filing deadlines for PGT-SR claims
Every claim has a time limit, and some are shorter than people expect. The deadline that applies depends on your state, the type of claim and the facts of your situation.
Do not wait, and do not assume it is too late. Tell us your story as soon as you can, and we will look at the time limits that apply to you.
Testing, consent and treatment records
Records worth collecting
Testing records
- The carrier parent's karyotype report
- PGT-SR work-up or feasibility report
- Embryo-by-embryo PGT-SR results
- Prenatal, newborn or retest results
Consent records
- PGT-SR consent forms
- Genetic counseling notes on method and limits
- Embryo disposition forms
Treatment records
- Biopsy, freezing and thaw logs
- Embryo transfer records
- Messages with the clinic or lab
- Bills and receipts
What happens after you contact CBW Law
What to expect
-
Share what happened
Tell us about the rearrangement, the testing and the outcome. You do not need every document.
-
We note the deadlines
We identify which state's rules may apply and how much time may remain.
-
We examine the method
With your permission, we gather records and check whether the method matched the rearrangement and what the report actually said.
-
We tell you where things stand
We explain what we found and whether we see a claim. Contacting us does not mean we will take the case.
Plain English
Medical, Health & Insurance
PGT-SR reports use chromosome terms most families have never seen. Here they are in plain language.
Chromosome changes
- Reciprocal translocation
- Two chromosomes swap pieces with each other.
- Robertsonian translocation
- A rearrangement joining two acrocentric chromosomes, whose centers sit near one end. It is a common reason for PGT-SR2.
- Inversion
- A segment breaks out, flips and reattaches in the same chromosome3.
- Karyotype
- A lab picture of a person's chromosomes used to describe the rearrangement.
Test methods
- FISH
- Fluorescent probes that light up chosen chromosome regions2.
- Array CGH
- A method that compares the amount of embryo DNA with reference DNA across the genome2.
- Resolution
- The smallest gain or loss a method can reliably detect.
- Uniparental disomy (UPD)
- Both copies of a chromosome inherited from one parent.
Pregnancy testing
- Chorionic villus sampling (CVS)
- A diagnostic test of placental tissue early in pregnancy.
- Amniocentesis
- A diagnostic test of cells in the fluid around the fetus.
Insurance and billing
- Feasibility or work-up fee
- A charge for checking whether a lab can test for a specific rearrangement.
- Out-of-pocket cost
- What you pay after any insurance payment.
- Explanation of benefits (EOB)
- An insurer's statement listing charges, payments and your share.
Questions
Frequently asked PGT-SR testing error questions
Answers to questions families ask about PGT-SR results.
Why would someone need PGT-SR?
What is the difference between a balanced and an unbalanced translocation?
Can PGT-SR tell if my embryo is a balanced carrier?
Only some methods can. FISH, array CGH and standard NGS cannot tell a balanced embryo from one with the usual arrangement2. SNP-based haplotyping can, usually with a reference sample such as a relative's DNA2, and newer sequencing methods with haplotype analysis have been reported to do the same4. Ask which method your lab used.
My embryo was reported balanced, but my child has a chromosome imbalance. Was that an error?
It might be, but not always. Mosaicism, changes below a test's resolution and unbalanced forms the method could not detect are known limits2. A review checks whether the method fit the rearrangement, whether samples were tracked correctly and whether the report matched the data.
Should I have prenatal testing after PGT-SR?
ACOG says diagnostic testing or screening is especially important after PGT-SR when PGT-A was not also done1. The choice is yours, made with your doctor or genetic counselor. Declining prenatal testing does not cause a lab error and does not change who is responsible for one.
Does PGT-SR also check the other chromosomes?
It depends on the method. Array-based platforms can assess chromosomes outside the rearrangement at the same time, while FISH checks only the regions its probes target2. Your report should say what was tested. If it does not, that gap is worth raising.
What is uniparental disomy, and can PGT-SR find it?
What records should I request for a PGT-SR review?
Start with the carrier parent's karyotype, the lab's work-up or feasibility report, embryo-by-embryo results and your consent and counseling notes. ESHRE says the patient file should include the karyotype, a counseling report on the method and its limits, and signed consent with a risk assessment2. Add transfer records and any prenatal or newborn test results.
How long do I have to file a PGT-SR lawsuit?
Every claim has a time limit, and it depends on your state and the facts. Contact us as soon as you can so a lawyer can check the deadline that applies to you.
Tell Us Your Story
PGT-SR can lower risk for families who carry a rearrangement, but only within the limits of the method used. When samples are mixed up, methods do not fit or limits go unexplained, families can face losses they worked hard to avoid.
If a PGT-SR result did not hold up, tell us your story. We will review what happened and explain your options honestly, without promising representation or any particular outcome.
Tell Us Your Story Call (800) 476-2416
This page is general information about PGT-SR testing errors. It is not legal or medical advice and does not create an attorney-client relationship. An unsuccessful cycle, a complication, an embryo loss or a testing limitation does not, by itself, establish that anyone was negligent. No outcome can be promised in any case.